Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors

Author:

Boiko Anastasiia S.1,Ivanova Svetlana A.12,Pozhidaev Ivan V.13,Freidin Maxim B.45,Osmanova Diana Z.13,Fedorenko Olga Yu12,Semke Arkadyi V.1,Bokhan Nikolay A.13,Wilffert Bob67,Loonen Anton J. M.68

Affiliation:

1. Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation;

2. National Research Tomsk Polytechnic University, Tomsk, Russian Federation;

3. National Research Tomsk State University, Tomsk, Russian Federation;

4. Department of Twin Research and Genetic Epidemiology, School of Live Course Sciences, King's College London, London, United Kingdom;

5. Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russian Federation;

6. Groningen Research Institute of Pharmacy, Unit of PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Groningen, the Netherlands;

7. Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands;

8. GGZ WNB, Mental health hospital, Bergen op Zoom, The Netherlands

Funder

Russian Scientific Foundation

Publisher

Informa UK Limited

Subject

Biological Psychiatry,Psychiatry and Mental health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3